Attenuated mutants of Staphylococcus aureus with two temperature-sensitive lesions: Isolation and characterization

Microbios

Volumn 94, Issue 378, 1998, Pages 95-102

  Sordelli, D O ^a   Cerquetti, M C ^a   Buzzola, F R ^a   Garcia V E ^a   Gomez M I ^a   Morris Hooke, A ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MIAMI UNIVERSITY   (United States)

Author keywords

Attenuated; Staphylococcus aureus; Temperature sensitive; Vaccine

Indexed keywords

BACTERIAL VACCINE; LIVE VACCINE; NITROSO DERIVATIVE;

ANIMAL; ARTICLE; CATTLE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEAT; IMMUNOLOGY; PHENOTYPE; POINT MUTATION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; BACTERIAL VACCINES; CATTLE; HEAT; NITROSO COMPOUNDS; PHENOTYPE; POINT MUTATION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VACCINES, ATTENUATED;

EID: 0031615949     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. CERQUETTI M. C., Gherardi M. M. and Sordelli D. O. 1990. Evaluation of different temperature-sensitive mutant phenotypes of Salmonella enteritidis as vaccine potentials. Curr. Microbiol. 21 225-8.
2. GARCIA V. E., Gherardi M. M., Iglesias M. F., Cerquetti M. C. and Sordelli D. O. 1993. Local and systemic immunity against Streptococcus pneumoniae: humoral responses against a non-capsulated temperature-sensitive mutant. FEMS Microbiol. Letters 108 163-8.
3. HALL B. G. 1990. Spontaneous point mutations that occur more often when advantageous than when neutral. Genetics 126 5-16.
4. LEE J. C. and Pier G. B. 1997. Vaccine-based strategies for prevention of staphylococcal diseases. In The Staphylococci in Human Disease. pp 631-54. Edited by K. B. Crossley and G. L. Archer. Churchill-Livingstone, New York, U.S.A.
5. MORRIS HOOKE A., Bellanti J. A. and Oeschger M. P. 1985. Genetically-attenuated bacterial vaccines: new approaches for safety and efficacy. Lancet 1 1472-4.
6. MORRIS HOOKE A. 1987. Attenuated live bacteria: vaccine efficacy and shortcomings. In Towards Better Carbohydrate Vaccines, pp 167-84. Edited by R. Bell Madsen and G. Torrigiani. John Wiley and Sons, New York, U.S.A.
7. MORRIS HOOKE A., Cerquetti M. C., Zeligs B. J., Wang Z., Hoberg K. and Bellanti J. A. 1993. Genetically stable temperature-sensitive mutants of Salmonella typhi induce protection from challenge in mice. Vaccine 11 1386-9.
8. NICKERSON S. C., Owens W. E. and Boddie R. L. 1995. Mastitis in dairy heifers: initial studies on prevalence and control. J. Dairy Sci. 78 607-18.
9. PROJAN S. J. and Novick R. P. 1997. The molecular basis of pathogenicity. In The Staphylococci in Human Disease. pp 55-81. Edited by K. B. Crossley and G. L. Archer. Churchill-Livingstone, New York, U.S.A.
10. SORDELLI D. O., Iglesias M. F., Cerquetti M. C., Catalano M. and Morris Hooke A. 1993. Temperature-sensitive mutants of Staphylococcus aureus: isolation and preliminary characterization. Curr. Microbiol. 27 125-9.
11. STEELE D. F. and Jinks-Robertson S. 1992. An examination of adaptive reversion in Saccharomyces cerevisiae. Genetics 132 9-21.